+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Diagnostics Market - Global Forecast 2026-2032- Product Image
Diabetes Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Diabetes Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887858
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetes Diagnostics Market is projected to reach USD 38.54 Billion in 2026. It is expected to continue growing at a CAGR of 8.41%, reaching USD 62.79 Billion by 2032.

Diabetes Diagnostics: Executive Summary

Diabetes diagnostics encompasses tests and workflows used to detect abnormal glucose regulation, classify diabetes, monitor glycemic control, and identify complications. Core approaches include fasting plasma glucose, oral glucose tolerance testing, glycated hemoglobin, random glucose testing, and glucose monitoring technologies. Demand is shaped by rising diabetes prevalence, earlier detection priorities, clinical guidelines, laboratory capacity, affordability, and the shift toward decentralized care.

How Diabetes Diagnostics Is Being Transformed

The landscape is moving from episodic testing toward continuous risk identification and longitudinal management. Point-of-care platforms, connected glucose monitors, laboratory automation, dried-blood-spot methods, and remote care are expanding access beyond traditional hospitals and laboratories. Interoperability, quality assurance, reimbursement policy, and clinician interpretation remain critical as diagnostic pathways become more distributed and digitally connected.

Artificial Intelligence Across Diabetes Diagnostics

Artificial intelligence is being applied to interpret glucose patterns, identify patients at elevated risk, support retinal and complication screening, and prioritize follow-up. Its practical value depends on representative training data, transparent validation, integration with clinical systems, and clear accountability for false positives and missed cases. Leaders should treat AI as decision support rather than a substitute for confirmatory testing, clinical judgment, or patient consent.

Regional Insights Across Diabetes Diagnostics

North America combines advanced laboratory infrastructure, strong adoption of connected monitoring, and established reimbursement pathways, while affordability and unequal access remain important issues. Europe emphasizes standardized care, prevention, privacy, and cross-border health-data governance. Asia-Pacific includes highly diverse systems, from sophisticated urban diagnostics to substantial rural access gaps, making scalable point-of-care solutions especially relevant. Latin America is balancing growing screening needs with uneven laboratory capacity and public-sector resource constraints. The Middle East is investing in chronic-disease prevention and digital health while addressing workforce and lifestyle-related risk. Africa faces pronounced challenges in screening coverage, continuity of care, supply reliability, and laboratory quality, with decentralized and community-based models offering practical opportunities.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN requires interoperable, lower-cost diagnostic pathways that can function across varied regulatory and health-system environments. BRICS members have substantial opportunities to strengthen primary-care screening, domestic manufacturing resilience, and equitable access while accounting for major differences in infrastructure. The European Union is focused on harmonized quality, data protection, prevention, and coordinated chronic-care policy. G7 systems generally have stronger diagnostic capacity but must address aging populations, workforce pressure, health inequity, and integration of data-rich technologies. GCC countries are emphasizing prevention, screening, and digitally enabled care, while NATO members face the shared need for resilient medical supply chains and continuity of essential diagnostics during emergencies.

Country-Level Signals Shaping Diabetes Diagnostics

Australia is positioned to extend screening through primary care, remote services, and Indigenous health programs. Brazil and Mexico must expand affordable diagnosis and continuity across geographically diverse public-health systems. Canada and the United States are advancing laboratory connectivity and glucose monitoring while addressing cost, access, and population disparities. China and India are scaling screening and diagnostic capacity across large, heterogeneous populations, with strong relevance for community and point-of-care models. France, Germany, Italy, Spain, and the United Kingdom are focused on prevention, integrated chronic-care pathways, workforce efficiency, and responsible data use. Japan and South Korea combine advanced technology adoption with priorities linked to aging, prevention, and system integration. Russia’s diagnostic environment is influenced by regional variation, supply resilience, and public-sector capacity.

Actions for Leaders in Diabetes Diagnostics

Industry leaders should prioritize clinically validated solutions that improve detection without creating unnecessary testing complexity. Build portfolios around interoperability, transparent performance claims, cybersecurity, and quality management across laboratory and point-of-care settings. Design tiered access models for under-resourced communities, support training for primary-care and community health workers, and establish post-market surveillance for connected and AI-enabled tools. Partnerships with health systems should focus on measurable outcomes such as earlier diagnosis, reliable follow-up, reduced repeat testing, and improved equity rather than technology adoption alone.

Research Methodology for the Executive Summary

This summary uses a structured review of established diabetes diagnostic modalities, clinical practice considerations, health-system trends, digital-health applications, and regional access conditions. Findings are synthesized qualitatively across the specified regions, country groupings, and countries, with emphasis on verified clinical and operational themes. No market estimates, market shares, forecasts, or company-specific assessments are included. Interpretation should be updated as diagnostic guidelines, reimbursement rules, regulatory requirements, and evidence for emerging technologies evolve.

Conclusion: Building More Accessible and Intelligent Diagnosis

Diabetes diagnostics is advancing toward earlier, more connected, and increasingly decentralized detection and monitoring. The strongest opportunities lie in combining reliable laboratory standards with accessible point-of-care services, interoperable data, responsible AI, and sustained follow-up. Progress will depend not only on technical performance but also on affordability, workforce capability, privacy, supply resilience, and equitable integration into routine care across diverse health systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Diabetes Diagnostics Market, by Technology
7.1. Introduction
7.2. Electrochemical Biosensor Technology
7.3. Optical Technology
7.4. Immunoassay Technology
7.5. Molecular Diagnostic Technology
7.6. Wearable Sensor Technology
8. Diabetes Diagnostics Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Home Care Settings
8.4. Hospitals & Clinics
8.5. Research Institutes
9. Diabetes Diagnostics Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Diabetes Diagnostics Market, by Test Type
10.1. Introduction
10.2. Blood Glucose Testing
10.3. Glycated Hemoglobin Testing
10.4. Continuous Glucose Monitoring
10.5. Ketone Testing
10.6. Insulin & C-Peptide Testing
10.7. Autoantibody Testing
11. Diabetes Diagnostics Market, by Sample Type
11.1. Introduction
11.2. Blood Samples
11.3. Interstitial Fluid
11.4. Urine Samples
11.5. Saliva Samples
12. Diabetes Diagnostics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. Diabetes Diagnostics Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. BRICS
13.5. European Union
13.6. ASEAN
13.7. GCC
14. Diabetes Diagnostics Market, by Country
14.1. Introduction
14.2. China
14.3. United States
14.4. Japan
14.5. India
14.6. Germany
14.7. United Kingdom
14.8. Australia
14.9. France
14.10. South Korea
14.11. Italy
14.12. Canada
14.13. Russia
14.14. Brazil
14.15. Mexico
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 3M Company
16.2. Abbott Laboratories
16.3. Acon Laboratories, Inc.
16.4. AgaMatrix, Inc.
16.5. Apex Biotechnology Corporation
16.6. ARKRAY, Inc.
16.7. B. Braun Melsungen AG
16.8. Beckman Coulter, Inc.
16.9. Becton, Dickinson and Company
16.10. Bio-Rad Laboratories, Inc.
16.11. Danaher Corporation
16.12. Diabetomics, Inc.
16.13. Diazyme Laboratories Inc
16.14. F. Hoffmann-La Roche Ltd.
16.15. ICON PLC
16.16. Medtronic PLC
16.17. Menarini Group
16.18. Nova Biomedical Corporation
16.19. Prestige Diagnostics
16.20. Sanwa Kagaku Kenkyusho Co, Ltd.
16.21. Siemens Healthineers AG
16.22. Sinocare, Inc.
16.23. Terumo Corporation
16.24. Tosoh Bioscience, Inc.
16.25. Trinity Biotech PLC
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Diabetes Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Diabetes Diagnostics Market, Research Design
FIGURE 3. Global Diabetes Diagnostics Market, Research Framework
FIGURE 4. Global Diabetes Diagnostics Market, Data Triangulation
FIGURE 5. Global Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Diabetes Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Diabetes Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Diabetes Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 9. Global Diabetes Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Diabetes Diagnostics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Diabetes Diagnostics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Diabetes Diagnostics Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 13. Global Diabetes Diagnostics Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Diabetes Diagnostics Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 15. Global Diabetes Diagnostics Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Diabetes Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Diabetes Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Diabetes Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Diabetes Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Diabetes Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Diabetes Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Diabetes Diagnostics Market Segmentation & Coverage
TABLE 2. Global Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Electrochemical Biosensor Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Electrochemical Biosensor Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Electrochemical Biosensor Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Optical Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Optical Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Optical Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Immunoassay Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Immunoassay Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Immunoassay Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Molecular Diagnostic Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Molecular Diagnostic Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Molecular Diagnostic Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Wearable Sensor Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Wearable Sensor Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Wearable Sensor Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 20. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 33. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 40. Global Blood Glucose Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Blood Glucose Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Blood Glucose Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Glycated Hemoglobin Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Glycated Hemoglobin Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Glycated Hemoglobin Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Continuous Glucose Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Continuous Glucose Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Continuous Glucose Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Ketone Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Ketone Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Ketone Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Insulin & C-Peptide Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Insulin & C-Peptide Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Insulin & C-Peptide Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Autoantibody Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Autoantibody Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Autoantibody Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 59. Global Blood Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Blood Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Blood Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Interstitial Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Interstitial Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Interstitial Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Urine Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Urine Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Urine Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Saliva Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Saliva Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Saliva Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 78. Europe Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. Europe Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Europe Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Europe Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. Europe Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 84. North America Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. North America Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. North America Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. North America Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. North America Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 89. North America Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 90. Latin America Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Latin America Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 92. Latin America Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Latin America Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Latin America Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 95. Latin America Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 96. Africa Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 98. Africa Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Africa Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Africa Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 101. Africa Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 102. Middle East Diabetes Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Middle East Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Middle East Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Middle East Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Middle East Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 107. Middle East Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 108. Global Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. NATO Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. NATO Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. NATO Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. NATO Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. NATO Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 114. NATO Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 115. G7 Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. G7 Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. G7 Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. G7 Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. G7 Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 120. G7 Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. BRICS Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. BRICS Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. BRICS Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. BRICS Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. BRICS Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 126. BRICS Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 127. European Union Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. European Union Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. European Union Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. European Union Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. European Union Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 132. European Union Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 133. ASEAN Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. ASEAN Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. ASEAN Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. ASEAN Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. ASEAN Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 139. GCC Diabetes Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. GCC Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 141. GCC Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. GCC Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. GCC Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 144. GCC Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 145. Global Diabetes Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. China Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 147. China Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. China Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. China Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. China Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 151. China Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. United States Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 153. United States Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. United States Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. United States Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. United States Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 157. United States Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 158. Japan Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 159. Japan Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Japan Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Japan Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Japan Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 163. Japan Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 164. India Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 165. India Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. India Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. India Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. India Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 169. India Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. Germany Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 171. Germany Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Germany Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Germany Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Germany Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 175. Germany Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 176. United Kingdom Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 177. United Kingdom Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. United Kingdom Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. United Kingdom Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. United Kingdom Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 181. United Kingdom Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 182. Australia Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 183. Australia Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Australia Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Australia Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. Australia Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 187. Australia Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. France Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 189. France Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. France Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. France Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. France Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 193. France Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 194. South Korea Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 195. South Korea Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. South Korea Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. South Korea Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. South Korea Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 199. South Korea Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. Italy Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 201. Italy Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Italy Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Italy Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Italy Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 205. Italy Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. Canada Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 207. Canada Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Canada Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Canada Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Canada Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 211. Canada Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. Russia Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 213. Russia Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 214. Russia Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Russia Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Russia Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 217. Russia Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 218. Brazil Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 219. Brazil Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 220. Brazil Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Brazil Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Brazil Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 223. Brazil Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. Mexico Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 225. Mexico Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Mexico Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Mexico Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Mexico Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 229. Mexico Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 230. Spain Diabetes Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Diabetes Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Spain Diabetes Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Spain Diabetes Diagnostics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Spain Diabetes Diagnostics Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 235. Spain Diabetes Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 236. Global Diabetes Diagnostics Market Share, by Key Player, 2025
TABLE 237. Global Diabetes Diagnostics Market, Key Experts

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Diabetomics, Inc.
  • Diazyme Laboratories Inc
  • F. Hoffmann-La Roche Ltd.
  • ICON PLC
  • Medtronic PLC
  • Menarini Group
  • Nova Biomedical Corporation
  • Prestige Diagnostics
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers AG
  • Sinocare, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech PLC

Related Topics

Related Reports

Diabetes Associated Ophthalmic Treatment Market - Global Forecast 2026-2032 - Product Image

Diabetes Associated Ophthalmic Treatment Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Diabetes Insulin Pumps Market - Global Forecast 2026-2032 - Product Image

Diabetes Insulin Pumps Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
AI in Diabetes Management - Global Strategic Business Report - Product Image

AI in Diabetes Management - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Diabetes Diagnostics - Global Strategic Business Report - Product Image

Diabetes Diagnostics - Global Strategic Business Report

  • Report
  • 346 Pages
  • Global
From
Diabetes Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Diabetes Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Diabetes Diagnostics Market

The Diabetes Diagnostics market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of diabetes. This market includes products and services used to detect and diagnose diabetes, as well as to monitor and manage the disease. These products and services include glucose meters, test strips, lancets, insulin pumps, continuous glucose monitoring systems, and other diabetes management tools. The Diabetes Diagnostics market is driven by the increasing prevalence of diabetes, the growing awareness of the disease, and the increasing demand for better management of the disease. Additionally, technological advancements in diabetes diagnostics have enabled the development of more accurate and efficient diagnostic tools. Some of the major companies in the Diabetes Diagnostics market include Abbott Laboratories, Roche Diagnostics, Johnson & Johnson, Bayer AG, and Medtronic. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.